Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan

• Autori principali: Akemi Egami (Autore), Shinji Takahashi (Autore), Takeshi Kokubo (Autore), Sreedevi Boggarapu (Autore), Eric Beresford (Autore)
• Natura: Libro
• Pubblicazione: Adis, Springer Healthcare, 2023-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Introduction Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder affecting several organs, including skin. We sought to assess the real-world effectiveness and safety of a topical sirolimus 0.2% gel treatment for TSC-related cutaneous manifestations. Methods We co...